Literature DB >> 29423578

Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis.

N Teich1,2, A Stallmach3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29423578     DOI： 10.1007/s10151-018-1754-9

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  5 in total

1.  Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis.

Authors:  My-Linh Tran-Minh; Matthieu Allez; Jean-Marc Gornet
Journal:  J Crohns Colitis       Date:  2017-09-01       Impact factor: 9.071

2.  De novo Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis and Inflammatory Bowel Disease Unclassified: Long-Term Follow-Up of a Prospective Inflammatory Bowel Disease Registry.

Authors:  Karen Zaghiyan; Jan P Kamiński; Galinos Barmparas; Phillip Fleshner
Journal:  Am Surg       Date:  2016-10       Impact factor: 0.688

3.  Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis?

Authors:  Mark A Samaan; Djuna de Jong; Saloomeh Sahami; Samantha Morgan; Konstantinos Fragkos; Sharmila Subramaniam; Klaartje Kok; Jesica Makanyanga; Ivana Barnova; Hajeena Saravanapavan; Ioanna Parisi; Simona Di Caro; Roser Vega; Farooq Rahman; Sara McCartney; Stuart L Bloom; Gijs R van den Brink; Mark Löwenberg; Cyriel Y Ponsioen; Christianne J Buskens; Pieter J Tanis; Anthony de Buck van Overstraeten; Andre DʼHoore; Willem A Bemelman; Geert R DʼHaens
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

4.  Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis.

Authors:  F Bär; T Kühbacher; N A Dietrich; T Krause; A Stallmach; N Teich; S Schreiber; J Walldorf; R Schmelz; C Büning; K Fellermann; J Büning; U Helwig
Journal:  Aliment Pharmacol Ther       Date:  2017-12-19       Impact factor: 8.171

5.  Prepouch Ileitis After Ileal Pouch-anal Anastomosis: Patterns of Presentation and Risk Factors for Failure of Treatment.

Authors:  Matteo Rottoli; Carlo Vallicelli; Eleonora Bigonzi; Paolo Gionchetti; Fernando Rizzello; Massimo P Di Simone; Gilberto Poggioli
Journal:  J Crohns Colitis       Date:  2018-02-28       Impact factor: 9.071
  5 in total
  1 in total

Review 1.  Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.

Authors:  Chiara Rocchi; Youssef Y Soliman; Marco Massidda; Salvatore F Vadalà di Prampero; Milutin Bulajic; Dario Sorrentino
Journal:  Dig Dis Sci       Date:  2021-06-07       Impact factor: 3.487
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.